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Enteric neurons, unlike sympathetic and sensory neurons that require target-derived neurotrophins for survival, do not undergo classical
caspase-3-mediated programmed cell death (PCD) during normal development. Whether parasympathetic neurons in the pancreas, which originate
from a subpopulation of enteric nervous system (ENS) precursors, or other parasympathetic neurons undergo PCD during normal mammalian
development is unknown. In GFRα2-deficient mice, many submandibular and intrapancreatic parasympathetic neurons are missing but whether
this is due to increased neuronal death is unclear. Here we show that activated caspase-3 and PGP9.5 doubly positive neurons are present in wild-
type mouse pancreas between embryonic day E15 and birth. Thus, in contrast to ENS neurons, intrapancreatic neurons undergo PCD via apoptosis
during normal development. We also show that, in GFRα2-deficient mice, most intrapancreatic neurons are lost during this late fetal period, which
coincides with a period of increased apoptosis of the neurons. Since the percentage of BrdU and Phox2b doubly positive cells in the fetal pancreas
and the number of intrapancreatic neurons at E15 were similar between the genotypes, impaired precursor proliferation and migration are unlikely
to contribute to the loss of intrapancreatic neurons in GFRα2-KO mice. Caspase-3-positive neurons were also found in GFRα2-deficient
submandibular ganglia around birth, suggesting that parasympathetic neurons depend on limited supply of (presumably target-derived neurturin)
signaling via GFRα2 for survival.
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In developing sympathetic and sensory ganglia, the number
of neurons is matched to the size of the target tissue by target-
derived neurotrophins required for the survival of these neurons
(Huang and Reichardt, 2001; Glebova and Ginty, 2005). In
contrast, caspase-3- and BAX-mediated programmed cell death
(PCD) is not observed during normal development of the enteric
nervous system (ENS), and the number of ENS neurons is
thought to be regulated by the proliferation of neuronal
precursors (Gianino et al., 2003). Little is known about how
the number of parasympathetic neurons is adjusted during
development in mammals. In the chick ciliary ganglion, about
half of the neurons undergo PCD during development (Land-⁎ Corresponding author.
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doi:10.1016/j.ydbio.2007.02.016messer and Pilar, 1974), and target-derived neurturin and ciliary
neurotrophic factor CNTF are candidate survival factors for
chick ciliary neurons in vivo (Finn et al., 1998; Hashino et al.,
2001). On the other hand, parasympathetic neurons in frog
cardiac ganglia match the growing target size with increased
precursor proliferation (Heathcote and Sargent, 1987a), and
PCD is not considered to play a role in their development
(Heathcote and Sargent, 1987b). The lack of PCD in enteric and
some parasympathetic neuron development may reflect the
proximity of these neurons to their targets.
Mammalian parasympathetic neurons require target-derived
neurturin signaling through a complex of GDNF-family
receptor α2 (GFRα2) and Ret receptor tyrosine kinase (for a
review, see Baloh et al., 2000; Airaksinen and Saarma, 2002).
Studies with neurturin- and GFRα2-KO (knock-out) mice have
shown that this signaling is important for the development of
parasympathetic target innervation. GFRα2 and Ret are found
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fetal development, as well as postnatally, while neurturin
mRNA is expressed in the targets they innervate (Widenfalk et
al., 1997; Golden et al., 1999; Rossi et al., 2000; Wanigasekara
et al., 2004). Cholinergic innervation of the small intestine, as
well as parasympathetic innervation of the exocrine and
endocrine pancreas, heart, mucosa of reproductive organs and
several cranial targets such as the salivary and lacrimal glands
are reduced in these mice (Enomoto et al., 2000; Heuckeroth et
al., 1999; Hiltunen et al., 2000; Rossi et al., 1999, 2000, 2003,
2005; Wanigasekara et al., 2004). In addition, lack of neurturin/
GFRα2 signaling leads to reduced soma size and/or reduced
neuron numbers in at least some parasympathetic ganglia
(Heuckeroth et al., 1999; Enomoto et al., 2000; Rossi et al.,
2000). In particular, GFRα2-KO mice show a ∼40% loss of
submandibular neurons and a ∼85% loss of intrapancreatic
neurons, but the mechanism underlying the neuronal losses
remains unclear (Rossi et al., 2003).
Like enteric neurons, intrapancreatic neurons form a plexus
of small ganglia and develop from a subgroup of vagal neural
crest-derived ENS precursors (Kirchgessner et al., 1992; Jiang
et al., 2003). These precursors start to migrate from the
primitive bowel to the developing pancreas presumably
between embryonic day E10 and E12.5 in mice (Jiang et al.,
2003; Rossi et al., 2003). The aim of this study was to determine
whether intrapancreatic and submandibular parasympathetic
neurons undergo PCD during normal mouse development and
whether signaling via GFRα2 is required for their survival (or
proliferation).Materials and methods
Animals and tissue processing
Most experiments used wild-type and GFRα2-KO littermates from
heterozygous parents maintained in a C57BL/6JOlaHsd (B6) background. At
embryonic day E17.5, three additional wild-type mice in F1 hybrid (B6×129S2)
background were used for pancreatic counts. Newborn (P0) wild-type and
GFRα2-KOmice were from separate litters. Vaginal plug date was considered to
be E0.5. Fetuses were harvested around midday, and their developmental age
was confirmed afterwards (Kaufman and Bard, 1999). The mice were genotyped
as described previously (Rossi et al., 1999). Newborn mice were deeply
anesthetized and perfused with phosphate buffered saline (PBS) following 4%
PFA in PBS (pH 7.5). Trunks and heads of fetuses and pups were fixed in 4%
PFA overnight at 4 °C and then gradually dehydrated and paraffin wax-
embedded. Additional fetuses were embedded in sucrose for cryosections. All
animal experiments were approved by the Animal Ethics Committee of the
University of Helsinki.
Immunohistochemistry
For activated caspase-3 and PGP9.5 double-label immunohistochemistry,
paraffin sections were rehydrated and the endogenous peroxidase activity was
blocked for 15 min in 0.5% H2O2 in 70% methanol. Antigen retrieval was
carried out in 10 mM sodium citrate buffer, pH 6.0. The buffer was pre-heated to
70 °C, and the slides were then heated in a microwave (650 W) three times for
4 min, avoiding boiling. Slides were blocked for 1 h in 5% normal donkey serum
followed by incubation in rabbit anti-activated caspase-3 (1:5000, Cell Signaling
Technology, Danvers, MA) and positive cells were detected by a Cy3 Tyramide
Signal Amplification (TSA) kit (PerkinElmer, Wellesley, MA). Sections were
then incubated with sheep anti-PGP9.5 (1:50, Serotec, Oxford, UK) followed bya 4-h incubation in donkey anti-sheep Cy2 (1:150) for detection. In some
experiments, double labeling was performed using rabbit anti-PGP9.5 (1:400,
Chemicon/Millipore, Billerica, MA) and donkey anti-rabbit Cy2 (1:200) which
gave similar results (data not shown). The rabbit anti-activated caspase-3
antibody (diluted 1:5000) was not recognized by the donkey anti-rabbit Cy2,
confirmed when the rabbit anti-PGP9.5 was omitted from the protocol. Finally,
the nuclei were stained with Hoechst 33258 (2 μg/ml in PBS, 2 min). In double-
label immunohistochemistry for insulin and PGP9.5, guinea pig anti-insulin
(1:3000, Abcam, Cambridge, UK) was detected using the Cy3-TSA system and
followed by staining for PGP9.5 as above. All secondary antibodies were from
Jackson ImmunoResearch (West Grove, PA). Slides were always incubated in
primary antibodies for 40 h at 4 °C, and 0.3% Triton X-100 in PBS was used as a
wash buffer.
To label proliferating cells, pregnant mice were injected intraperitoneally
with BrdU (Sigma, 6 mg/100 g diluted in saline) 2.5 h before sacrifice. After
blocking endogenous peroxidase as above and antigen retrieval overnight in
PBS at 70 °C, 10-μm-thick cryosections were incubated 2.5 h in rabbit anti-
Phox2b (1:3000, a kind gift from Dr. Pattyn (Pattyn et al., 1999)) and detected
with a TSA-fluorescein system (PerkinElmer). This was followed by reblocking
the peroxidase activity as above and blocking unspecific binding in 10% normal
goat serum. Sections were then incubated with mouse anti-BrdU antibody
(Amersham, prediluted containing nuclease and 3% normal goat serum) for
1.5 h. The BrdU antibody was detected with peroxidase-conjugated goat anti-
mouse antibody (DAKO) and the TSA-Cy3 system as above.
For Phox2b-PGP9.5 double labeling, cryosections were first stained for
Phox2b using the TSA-Cy3 for detection followed by staining with sheep anti-
PGP9.5 as above. For terminal deoxytransferase-mediated deoxyuridine
triphosphate nick-end labeling (TUNEL) and PGP9.5 double labeling, paraffin
or cryosections were labeled using rabbit anti-PGP9.5 as above followed by
TUNEL staining according to the manufacturer's instructions (ApopTag
Peroxidase In Situ Apoptosis Detection Kit) and detected using TSA-Cy3.
Nuclear area of PGP9.5-positive cell profiles
Twenty to forty intrapancreatic and submandibular PGP9.5-positive cell
profiles were randomly selected from each mouse, and the areas of nuclear
profiles were determined using ImagePro program (Media Cybernetics, Silver
Spring, MD). The mean nuclear area of intrapancreatic PGP9.5-positive cell
profiles was similar between wild-type and GFRα2-KO mice at E15.5 (WT:
63±0.3; KO: 61±1 μm2), E16.5 (WT: 60±2; KO, 59±2 μm2), E17.5 (WT:
70±2; KO: 69±0.2 μm2) and birth (WT: 71±2; KO, 68±2 μm2; n=3 for each
genotype and time point). Thus, the relative proportion of intrapancreatic
neurons between the genotypes (Fig. 2) could be calculated directly from the raw
numbers of neuronal nuclear profiles. In the submandibular ganglion, the mean
nuclear area (of PGP9.5-positive profiles) was smaller in GFRα2-KO mice at
birth (WT: 59±2 μm2 versus KO: 48±1 μm2; P<0.05, n=3 in both groups) but
not at E17.5 (WT: 51±1 μm2 versus KO: 52±1 μm2; P=0.5, n=2 in both
groups).
Cell counting
PGP9.5-positive and PGP9.5-activated caspase-3 double-positive cell
profiles with a clearly visible nucleus were counted by an observer blind to
the genotype. For intrapancreatic ganglia, profiles were counted from serial
7-μm-thick transversal sections cut through the pancreas using systematic
random sampling of 1/10 (P0.5) or 1/5 (other time points) of the sections. If
PGP9.5-positive cells were located on the border of the gut and pancreas,
immunopositive cells belonging to the pancreas were determined by drawing a
line between the two closest points where the gut and pancreas could clearly be
discerned. For comparison, neuron profiles in left paravertebral sympathetic
chain and dorsal root ganglia (DRG) were counted from every 25th section at
the level of the pancreas. For ENS, five or more random sections of the gut
(from duodenum to colon) were counted in each animal. The percentage of
apoptotic neurons was calculated as the ratio of PGP9.5-activated caspase-3
double-positive cell profiles to all PGP9.5-positive profiles. For the sub-
mandibular ganglion, apoptosis was also estimated stereologically using the
Abercrombie Method 2 (http://www.nervenet.org/papers/Aberfp.html#Method2)
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and 14-μm sections were collected on slides, leaving a 14-μmgap in between every
section pair. Immunopositive profiles were counted from the adjacent 7-μmand14-
μm sections. Subtraction of the sum of 7-μm section counts from the sum of 14-μm
section counts results in a theoretically unbiased estimate of the cell number.
Statistical analysis
All results are expressed as mean±SEM. Statistical significance of neuron
profile number and nuclear area data, as well as significance of differences in the
percentages of dying neurons, was determined using the two-tailed Student's
t-test, assuming unequal variance. P<0.05 was considered statistically
significant.Results
Most intrapancreatic neurons in GFRα2-KO mice are lost
during late fetal development
To label intrapancreatic neurons, we used antibodies against
PGP9.5, a pan-neuronal marker that has previously been used to
identify neurons in the fetal (E12.5 and E15) and neonatal (P0
and P4) mouse pancreas (Jiang et al., 2003; Rossi et al., 2003).
Because PGP9.5 is expressed also in the progenitors of
pancreatic endocrine cells in developing rats (Yokoyama-
Hayashi et al., 2002), we first established using double-label
immunohistochemistry for PGP9.5 and insulin that the strongly
PGP9.5-positive cell profiles in our samples were not islet cells
(Figs. 1a–c). From E15.5 to E17.5, some islet cells stained for
PGP9.5, but the staining was very weak compared with cells in
intrapancreatic ganglia, many of which were also positive for
Phox2b, a marker of autonomic neurons and their precursors
(Figs. 1d–e). Some ENS precursors in the developing mouse
gut express pan-neuronal markers such as PGP9.5 (Sidebotham
et al., 2001; Gianino et al., 2003; Young et al., 2005). Thus,Fig. 1. (a–c) PGP9.5 (green) is strongly expressed in E17.5 wild-type intrapancreatic g
faint PGP9.5 staining (asterisk) and are thus easily distinguished from the neurons. (d–
Cells strongly positive for PGP9.5 (green) also express transcription factor Phox2balthough we assume that the strongly PGP9.5-positive cells in
mouse intrapancreatic ganglia after E15 are differentiated
neurons, we cannot exclude the possibility that some represent
neuronal precursors.
Counting of intrapancreatic PGP9.5-positive profiles from
GFRα2-KO and wild-type mice at different developmental time
points showed that the neuronal loss develops during the late
fetal period (Fig. 2). At E15.5 and E16.5, no significant
difference in the total number of intrapancreatic PGP9.5-positive
profiles was seen between genotypes (E15.5 WT, 1900±100,
versus KO: 1700±100; E16.5 WT: 3200±500, versus KO:
2700±400), suggesting that the migration of neuronal pre-
cursors from the bowel to the pancreas is normal in GFRα2-KO
mice. In contrast, at E17.5, the number of intrapancreatic
neuronal profiles was significantly (∼45%) lower in GFRα2-
KO than in wild-type fetuses (WT: 3600±200, versus KO:
2000±200; P<0.0005). By birth, GFRα2-KO mice had ∼75%
less intrapancreatic PGP9.5-positive profiles than wild-type
mice (WT: 3400±200, versus KO: 900±100; P<0.005),
indicating that most of the ∼85% intrapancreatic neuron loss
seen at postnatal day P4 (Rossi et al., 2003) develops during the
last days of fetal life (Fig. 2).
Proliferation of intrapancreatic neuronal precursors is
unaffected in GFRα2-deficient mice
To address whether impaired precursor proliferation would
contribute to the loss of intrapancreatic neurons in GFRα2-KO
mice, we counted the percentage of Phox2b-positive cells in
E15.5 and E17.5 pancreatic ganglia that were also BrdU-
positive (Fig. 3). The assessment of colocalization was
unambiguous since both markers labeled the nucleus. The
percentage of proliferating Phox2b-positive nuclei was sig-
nificantly higher at E15.5 than at E17.5 (as expected), butanglia (arrow), whereas islet cells identified by insulin antibody (red) show only
f) Confocal microscopic images of an E15.5 wild-type intrapancreatic ganglion.
(red).
Fig. 2. Comparison of numbers of intrapancreatic PGP9.5-positive cell profiles
between GFRα2-KO and wild-type mice at different developmental time points.
At E15.5, no significant difference exists in the number of PGP9.5-positive
profiles between genotypes (P=0.4). Soon thereafter, the relative number of
intrapancreatic PGP9.5-positive profiles starts to decrease in GFRα2-KO
fetuses, reaching statistical significance at E17.5, when the KO mice have
∼45% fewer intrapancreatic neurons than wild-type animals. At birth, the deficit
in KO intrapancreatic neuron profile number is already close to the final deficit
(∼85% loss) observed from P4 onwards. P4 and adult data are from a previous
study (Rossi et al., 2003) and are shown for comparison. The number of animal
pairs analyzed at each time point is indicated in parentheses. **, P<0.005; ***,
P<0.0005 compared with wild-type mice.
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0.5%, E17.5 WT 2.1±0.4%; KO 2.7±0.5%, n=2 in both
genotypes and time points). These results suggest that the
proliferation of intrapancreatic neuronal precursors is not
impaired in GFRα2-KO mice.
Developing intrapancreatic but not enteric neurons undergo
PCD that is augmented in the absence of GFRα2
Consistent with a previous study reporting the absence of
PCD in the developing mouse ENS (Gianino et al., 2003), the
percentage of PGP9.5-expressing cells in the gut that were
positive for activated caspase-3 was very low at all time points
examined in both wild-type and GFRα2-KO mice (Figs. 4 andFig. 3. Proliferation of intrapancreatic neuronal precursors in wild-type and GFRα2
BrdU/Phox2b double-positive profiles to Phox2b-positive profiles) in E15.5 and E17
of E15.5 GFRα2-KO mouse pancreas demonstrates a proliferating BrdU/Phox2b do5a) (E15.5 WT: 0.04±0.02% versus KO: 0.1±0.03; E16.5 WT:
0.11±0.02% versus KO: 0.17±0.03%; E17.5 WT: 0.05±0.01%
versus KO: 0.05±0.01%; P0 WT: 0.02±0.01% versus KO:
0.04±0.02%). As a positive control, we counted caspase-3-
positive neurons in paravertebral sympathetic (Fig. 5b) and
spinal sensory ganglia at the pancreas level. The period of PCD
in mouse sympathetic ganglia starts around E15 and continues
postnatally (Francis et al., 1999), whereas most cell death in
spinal sensory ganglia occurs before E15 (Farinas et al., 1996;
White et al., 1998). In accord with this, the percentage of
apoptotic (activated caspase-3-positive) neurons increased
towards birth in sympathetic paravertebral ganglia, while the
percentage was high at E15.5 and then decreased progressively
towards birth in DRG (Fig. 4). The percentages of apoptotic
cells in these ganglia were similar between genotypes,
consistent with our previous findings that signaling via
GFRα2 is not important for the survival of sympathetic or
DRG neurons during development (Rossi et al., 1999; Lindfors
et al., 2006). We also tried to confirm the lack of PCD in
developing ENS using TUNEL/PGP9.5 double staining.
Unfortunately, TUNEL-positive cells in the peripheral nervous
system were often PGP9.5-negative (Supplementary Figure).
Nevertheless, while relatively many (39/1058) TUNEL-positive
cells were detected in E17.5 sympathetic chain ganglia, as
expected, very few (0/426) TUNEL-positive cells were detected
in close vicinity of PGP9.5-positive enteric neurons. This is
consistent with the result obtained using activated caspase-3
(see Fig. 4) indicating that very few enteric neurons undergo
apoptosis in the fetal mouse.
In contrast to the virtual lack of apoptosis in developing
ENS, despite the reported common developmental origin of
enteric and intrapancreatic neurons, cell profiles double-
positive for PGP9.5 and activated caspase-3 were relatively
numerous in wild-type mouse intrapancreatic ganglia between
E15 and P0 (Figs. 4 and 5c–f). At E15.5, no significant
difference existed in the percentage of dying PGP9.5-positive
cell profiles in the pancreas between genotypes (WT: 1.1±
0.1%, KO: 1.2±0.1%). On the contrary, apoptosis was
significantly increased in the intrapancreatic ganglia from
GFRα2-KO mice (as compared with wild-type littermates) at
E16.5 (WT: 0.8±0.05% versus KO: 3.0±0.2%; P=0.01) and
E17.5 (Figs. 5g–j; WT: 0.7±0.2% versus KO: 4.1±0.6%;
P<0.005) — i.e. at the same time the loss of intrapancreatic-KO mouse fetuses. (a) Percentage of proliferating neuronal precursors (ratio of
.5 pancreas is similar between the genotypes. (b–d) Confocal microscopic image
uble-positive intrapancreatic precursor (arrow).
Fig. 4. Percentage of apoptotic neurons (ratio of cell profiles double-positive for activated caspase-3 and PGP9.5 to all PGP9.5-positive profiles) in different peripheral
ganglia of E15.5, E16.5, E17.5 and P0.5 wild-type and GFRα2-KO mice. Percentage of activated caspase-3-positive neurons is significantly increased in GFRα2-KO
mice in the intrapancreatic (at E16.5 and E17.5) and submandibular (at E17.5 and P0) ganglia. No differences between the genotypes are observed in the other ganglia.
Note that, while intrapancreatic neurons undergo PCD during normal development, PCD is virtually lacking in the developing ENS. In sympathetic paravertebral
ganglia, PCD increases towards birth (and continues postnatally), whereas in DRG, the period of PCD is over by birth. For SMG, the number of glands analyzed and
for the other ganglia the number of animals analyzed are indicated in parentheses. **, P=0.01; ***, P<0.005 compared with wild-type mice.
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when the loss of these neurons was already close to the final
level (Fig. 2), the percentage of apoptotic neurons was no longer
clearly elevated in GFRα2-KO mice (WT: 0.4±0.3% versus
KO: 0.8±0.2%; P=0.29). Thus, intrapancreatic neurons
undergo PCD, and increased apoptosis contributes to the loss
of intrapancreatic parasympathetic neurons in GFRα2-KO mice
during the last days of fetal development.
Signaling via GFRα2 is also important for the survival of
submandibular neurons
Increased neuronal cell death in GFRα2-KO intrapancreatic
ganglia prompted us to examine whether defects in cell survival
could also explain the previously reported ∼30% loss of
submandibular neurons in newborn GFRα2-KO mice (Rossi et
al., 2000). Apoptosis (i.e. percentage of activated caspase-3-
positive neurons) was significantly increased in GFRα2-KO
submandibular ganglia at birth, estimated by standard profile
counting (WT: 0.3±0.1% versus KO: 2.2±0.3%; P<0.001) or
stereologically (WT: 0.8±0.3% versus KO: 3.3±0.2%;P<0.001,
n=6 submandibular glands from three littermate mice in both
groups). Furthermore, at E17.5, the percentage of apoptotic
profiles was increased in GFRα2-KO mice (WT: 0.05±0.01%
versus KO: 0.85±0.13%; P=0.01, n=4 submandibular glands
analyzed from two mice in both groups) (Fig. 4).
Discussion
Our results show that GFRα2 signaling is important in vivo
for the survival of parasympathetic intrapancreatic neurons
during late fetal development and submandibular neurons
around birth. Thus, increased apoptosis contributes to the loss
of intrapancreatic and submandibular neurons observed inGFRα2-KO mice. Signaling via GFRα2, by contrast, does not
seem to influence the amount of PCD in sympathetic
paravertebral, sensory (DRG) or ENS ganglia during fetal
development. In addition, we show that, despite their proposed
common developmental origin, intrapancreatic but not enteric
neurons undergo PCD during normal fetal development.
Activated caspase-3 and TUNEL are established markers
used to study ontogenetic neuronal cell death (Srinivasan et al.,
1998; Oppenheim et al., 2001; Urase et al., 2003). Of these,
activated caspase-3 seemed more suitable than TUNEL to
distinguish apoptotic neurons in the small peripheral ganglia
because TUNEL-positive cells in the ganglia were often
PGP9.5-negative, presumably because TUNEL detects cells at
a later stage of death than activated caspase-3. Other pan-
neuronal markers (such as Hu) could remain detectable during
the later cell death (Lee et al., 2001). Although activated
caspase-3 and TUNEL may not detect the full set of neuronal
death (e.g. Borsello et al., 2002), to our knowledge TUNEL-
and caspase-negative naturally occurring developmental death
of neurons has not been clearly demonstrated (Yuan et al.,
2003). For example, the normal death of embryonic chick
ciliary ganglion neurons is morphologically non-apoptotic,
classified as cytoplasmic or necrotic type of PCD (Pilar and
Landmesser, 1976), but seems however detectable by TUNEL
(Lee et al., 2001). Nevertheless, the possibility of non-apoptotic
PCD of the developing enteric neurons cannot be fully
excluded.
Future studies are warranted to address why intrapancreatic
and enteric neurons differ with respect to ontogenetic caspase-
3-mediated apoptosis and GFRα2 signaling even though the
neuronal precursors in pancreas migrate from the fetal bowel.
Enteric neurons are able to die via apoptosis, e.g. following
injury (Boyer et al., 2005; Anitha et al., 2006), suggesting
that the lack of ontogenetic PCD in enteric neurons may not
Fig. 5. Examples of mouse peripheral ganglia stained for activated caspase-3 (red) and PGP9.5 (green). DNA is stained with Hoechst 33258 (blue) to reveal the nuclear
pyknosis of apoptotic cells. (a) Absence of apoptotic cells in the developing ENS. In this example of E17.5 wild-type myenteric plexus, none of the PGP9.5-positive
myenteric neurons stains for activated caspase-3. (b) Apoptotic neurons in a paravertebral sympathetic ganglion of E17.5 wild-type fetus (arrows). (c–j) Apoptotic
neurons with pyknotic nuclei (arrows) in intrapancreatic ganglia of both E17.5 wild-type (c–f) and GFRα2-KO (g–j) mice. (k–m) Apoptotic activated caspase-3-
positive cells in newborn GFRα2-KO submandibular ganglion.
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cular migration of a subpopulation of enteric precursors to the
pancreas (and to the submucosa) requires netrin/DCC
signaling (Kirchgessner et al., 1992; Jiang et al., 2003). It
is unclear whether the enteric precursors destined to become
pancreatic neurons are predetermined (and different from their
neighbors in the fetal bowel) or do they change their
phenotype and become survival-dependent on GFRα2
signaling in response to signals they receive from the
pancreatic microenvironment. Interestingly, similar to the
intrapancreatic neurons, submucosal cholinergic neurons in
the stomach require GFRα2 signaling for target innervation
(our unpublished data). Thus it remains to be studied whether
the submucosal subpopulation of enteric neurons might
require GFRα2 signaling also for survival during postnatal
development.
Neurturin mRNA is expressed in the developing mouse
pancreas already at E14, but its expression is increased at E16
and E18 (Golden et al., 1999). Notably, the increase in
neurturin expression coincides with the time of increased cell
death in GFRα2-KO intrapancreatic ganglia (E16.5). Soon
after (at E17.5), a significant decrease in the number of
PGP9.5-positive cells is seen in the GFRα2-KO pancreas.
Similarly, the increase of neurturin expression in the fetal
submandibular salivary gland from E14 onwards (Golden et
al., 1999) (and our unpublished data) precedes the increase in
death of submandibular neurons in GFRα2-KO mice (this
study) and is accompanied by a decrease in their number as
compared with wild-type mice (Rossi et al., 2000). Thus,
neurturin, the primary, and in vivo the only-known ligand
signaling via GFRα2 (Heuckeroth et al., 1999; Rossi et al.,
1999; Airaksinen and Saarma, 2002), is the most likely target-
derived survival factor for the intrapancreatic and subman-
dibular neurons during fetal development. However, as
GFRα2-KO mice develop a postnatal growth retardation
(Rossi et al., 1999) that is not observed in neurturin-KO mice
(Heuckeroth et al., 1999), a ligand other than neurturin,
possibly GDNF, might also activate Ret via GFRα2 in some
tissue(s) important for growth.
We show that the majority of intrapancreatic neurons in
GFRα2-KO mice are lost between E16 and birth. Is the
increase in neuronal cell death sufficient alone, or do
additional mechanisms, such as reduced migration or prolif-
eration of neuronal precursors, contribute to the deficit? Our
results suggest that the migration of enteric precursors from the
bowel to the developing pancreas is normal in GFRα2-KO
mice since no difference was present in the number of PGP9.5-
positive intrapancreatic profiles between the genotypes at
E15.5, when the number of intrapancreatic neuronal profiles is
more than half of the maximum number counted at E17.5. This
is consistent with the idea that most enteric crest-derived cells
migrate into the pancreas from E13 to E15 (Jiang et al., 2003),
and thus a possible defect in migration after E15.5 would not
significantly contribute to the deficit. Moreover, our analysis of
the mice after BrdU labeling indicated no difference between
genotypes in the number of proliferating Phox2b-positive
neuronal precursors in the pancreas at E15.5 or E17.5, makingit unlikely that reduced precursor proliferation contributes to
loss of intrapancreatic neurons. Assuming that apoptotic
neurons are positive for activated caspase-3 (and PGP9.5) for
only a few hours (during the late phase of death), we propose
that the up to fivefold increase in apoptosis in GFRα2-KO
intrapancreatic ganglia (as compared to wild-type) is sufficient
to account for most, if not all, of the neuronal loss.
We also found an increased number of caspase-3-positive
apoptotic neurons in the SMG of GFRα2-KO mice. Although
the increased apoptosis could be secondary due to lack of target
innervation (Rossi et al., 2000), a direct survival promoting role
of GFRα2 would be consistent with previous reports that NRTN
supports the survival of SMG neurons in vitro (Cacalano et al.,
1998). Wild-type SMG had few apoptotic neurons at E17.5
(0.05%) and at birth (∼0.5%), suggesting that PCD is not a
major determinant of SMG neuron number during late fetal
development, but it remains possible that additional SMG
neurons undergo PCD postnatally.
In conclusion, we have demonstrated that neurons in two
different parasympathetic ganglia depend on GFRα2 for
survival. Thus, naturally occurring PCD in parasympathetic
neurons is dependent on a limited supply of presumably
neurturin signaling via GFRα2 for survival. Most parasympa-
thetic neurons require GFRα2 signaling for target innervation
and cell size, but some (e.g. in the sphenopalatine ganglion)
neurons apparently do not need it for survival (Rossi et al.,
2000). We hypothesize that a correlation exists between the
extent of cell death occurring naturally and that occurring in
GFRα2-KO mice in different parasympathetic ganglia.
Another area for future research is uncovering the mechanism
that prevents some parasympathetic and enteric neurons from
undergoing PCD even if they depend on GFRα2 signaling for
target innervation and cell size.
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